ATF2 and hepatocellular carcinoma: It is therefore plausible that after upregulation of CCT3 in HCC, CCT3 binds to TFs (including ATF2), sequesters and thereby prevents TFs from binding to promoter regions of genes involved in lipid metabolism and LINC00326 (online supplemental figure S11a).